Figures computed from official regulatory filings — .
Analysttarget 20 USD (+293%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 8.65% · institutions 52.75% · short 2.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NextCure, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Baltimore, Maryland.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
20 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Simcere Zaiming, Inc. | Sell | $184.8K | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $100K | conv 30 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $124.5K | conv 30 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $490K | conv 45 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $120.3K | conv 31 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $100K | conv 30 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $38.4K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $385.8K | conv 40 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $16.4K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $248.6K | conv 35 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $9.1K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $31.7K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $8K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $39K | conv 30 | SEC |
| Jones Elaine V | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feigal Ellen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Houston John G | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Borgman Anne Elizabeth | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KABAKOFF DAVID S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Webster Stephen W | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kundu Sourav | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Shaw Kevin G. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Richman Michael | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cobourn Steven P. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mayer Timothy | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |